E

Elanco

Global animal health pharmaceutical company

Advisor – Global Regulatory Affairs CMC Biologicals

Regulatory & Quality (Life Sciences)Confirmed live in the last 24 hours
Full-timeNo salary listedIn-person

About the Job

Requirements

  • A Bachelor of Science degree.
  • Excellent understanding of European Union regulatory legislation for veterinary vaccines.
  • Fluency in English and German.
  • At least 8 years of experience in global regulatory affairs.
  • Excellent communication skills, including scientific writing.
  • Strong planning and organizational skills.
  • Flexibility and adaptability to leverage new technologies.
  • Ability to work cross-functionally and influence decisions in a matrix environment.

Responsibilities

  • Design and develop regulatory CMC strategy for post-approval changes and geographic expansion of marketed biological products, balancing business benefit with regulatory compliance.
  • Collaborate and partner with internal groups in research and development, manufacturing, quality, and global regulatory business partners.
  • Lead CMC regulatory pre-submission preparation; communicate strategy, key issues, and critical topics to interdisciplinary project teams; and apply the global strategy to submissions.
  • Ensure required documentation, content, and timelines for global submissions are communicated to appropriate teams and tracked according to functional procedures.
  • Author high-quality CMC regulatory documentation for submission while applying global regulatory CMC strategies and assuring regulatory compliance.
  • Stay informed about changing regulatory guidelines, requirements, and industry technical trends, and proactively share that information within the organization.

Desired Qualifications

  • Experience developing regulatory CMC strategy for Europe (European Medicines Agency) and most countries worldwide, preferably within vaccines, biotechnology, CMC, or related areas.

About the Company

Elanco

Global animal health pharmaceutical company

Elanco is a global animal health company that develops and sells medicines, vaccines, and preventive care products for livestock and pets. Its portfolio includes prescription medicines, vaccines, parasite controls, and other welfare products used by veterinarians, farmers, and pet owners to prevent or treat disease and improve wellbeing. Since becoming independent after separating from Eli Lilly and acquiring Bayer Animal Health in 2020, it ranks as the world’s second-largest animal health company with a broad, globally distributed product line and direct-to-consumer capabilities. Its goal is to improve animal health and welfare worldwide by providing effective, accessible products and services while growing sustainably.

Company size
5,001-10,000
Company stage
IPO
Headquarters
Indianapolis, IN
Founded
1954

Recently Posted Jobs

Explore more opportunities at Elanco

See more jobs